SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC updates on CAN-2409especially evidence of systemic immune activation and viral clearance in the prostate programare drawing attention alongside the planned BLA filing, supported by previously positive Phase 3 results. Bulls see the data as strengthening the regulatory case, while skeptics question filing execution and management transparency and worry about financing or dilution.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads planned sale of its prenatal-testing business to Labcorp has driven attention, with traders weighing the cash proceeds and focus on oncology against the revenue the business will no longer contribute. Recent Q3 results, including a revenue beat and higher 2026 revenue guidance, added support, though concerns about ongoing losses and execution remain.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs better-than-expected quarterly results and stronger outlook are driving attention, with investors pointing to AI-related demand for its semiconductor inspection and process-control equipment. Bulls see the report as support for a recovery after the steep selloff, while skeptics remain concerned about the chip-equipment capex cycle.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Traders are debating whether reported J&J menin-inhibitor data threatens Kuras ziftomenib (KOMZIFTI) in frontline AML, or is only a limited competitive concern until further data, including at ASH, clarify the comparison. Some see risk in the venetoclax-exposed patient results, while bullish traders point to KOMZIFTIs commercial ramp and combination-trial prospects.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Attention centers on Anthropics anticipated IPO and S-1 filing, which traders see as a potential catalyst for DXYZ through its private-company holdings and a chance for its share price to catch up with estimated NAV. The community is divided: bulls expect IPO-related enthusiasm and higher underlying valuations, while skeptics point to possible delays, Anthropics financial risks, dilution, and DXYZs muted price response despite the hype.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

Discussion centers on MSTYs fluctuating, recently reduced weekly distributions and continued price/NAV erosion in the MSTR- and Bitcoin-linked options-income ETF. Some holders remain focused on weekly cash flow and accumulate shares, while critics argue payouts do not offset losses and question the funds long-term sustainability.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins pullback and heavy spot-ETF redemptions are driving IBIT discussion, with traders debating whether a test of the 50-week trend line signals further downside or a support area for dip buyers. Mike McGlones renewed bearish outlook adds to the caution, while some investors continue to argue the weakness is temporary.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,188,857.28849125 with 591,038,208.99550009 in circulation. The last known price of Solana is 89.31595776 USD and is down -0.85 over the last 24 hours. It is currently trading on 1189 active market(s) with $833,801,627.68 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solanas continued decline and struggle below $100 amid broad crypto weakness are driving discussion, with traders watching support and debating whether the selloff has further to run. Some point to the Binance security incident as an added confidence risk, while others see lower prices as a buying opportunity and are accumulating or staking.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleafs failed bid for Aurora is a major focus, with Organigram winning the acquisition and traders divided over whether Curaleaf avoided an unfavorable deal or will pursue another target. Discussion also weighs its recent earnings and the broader Schedule III process, which remains a hoped-for tailwind for U.S. cannabis operators.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers pullback has fueled debate over whether AI automation could shrink employee and application seats, pressuring its per-user security model. Bears see a risk to growth and budgets, while bulls argue AI creates more security needs; options activity also points to uncertainty about direction.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
